Metis Global Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41M Sell
30,863
-5,649
-15% -$456K 0.05% 262
2026
Q1
$3.16M Sell
36,512
-4,159
-10% -$398K 0.08% 212
2025
Q4
$3.91M Sell
40,671
-2,611
-6% -$254K 0.09% 187
2025
Q3
$4.12M Sell
43,282
-2,692
-6% -$247K 0.1% 177
2025
Q2
$4.01M Sell
45,974
-5,374
-10% -$456K 0.1% 165
2025
Q1
$4.61M Buy
51,348
+8,299
+19% +$743K 0.13% 139
2024
Q4
$3.44M Sell
43,049
-11,189
-21% -$969K 0.1% 165
2024
Q3
$4.88M Buy
54,238
+759
+1% +$63.9K 0.15% 119
2024
Q2
$4.21M Buy
53,479
+493
+0.9% +$40.4K 0.14% 118
2024
Q1
$4.62M Sell
52,986
-432
-0.8% -$36.9K 0.17% 109
2023
Q4
$4.4M Sell
53,418
-7,849
-13% -$598K 0.18% 108
2023
Q3
$4.8M Buy
61,267
+7,634
+14% +$639K 0.23% 81
2023
Q2
$4.73M Sell
53,633
-88
-0.2% -$7.58K 0.25% 72
2023
Q1
$4.33M Buy
53,721
+17,213
+47% +$1.4M 0.28% 71
2022
Q4
$2.84M Buy
36,508
+11,817
+48% +$958K 0.25% 93
2022
Q3
$1.99M Buy
24,691
+1,129
+5% +$101K 0.32% 65
2022
Q2
$2.11M Buy
23,562
+2,322
+11% +$235K 0.34% 67
2022
Q1
$2.36M Buy
21,240
+10,119
+91% +$1.07M 0.28% 64
2021
Q4
$1.15M Buy
+11,121
New +$1.29M 0.32% 70

Other funds holding MDT

Metis Global Partners's MDT Position: Q2 2026 in Review

Metis Global Partners reduced its Medtronic (MDT) stake by 15% in Q2 2026, selling an estimated $456K and leaving 30,863 shares worth $2.41M. The position accounts for 0.05% of the portfolio, ranked #262.

Metis Global Partners first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.88M in Q3 2024. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Metis Global Partners held 30,863 shares of Medtronic worth $2.41M as of Q2 2026.
  • Metis Global Partners sold 5,649 Medtronic shares in Q2 2026, an estimated $456K.
  • Medtronic made up 0.05% of Metis Global Partners's portfolio in Q2 2026, its #262 holding.
  • Metis Global Partners first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's Medtronic position peaked at $4.88M in Q3 2024.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.